CHEK2 and invasive breast carcinoma: Based on the findings of this study, we agree that interpretation of the CHEK2 mutation analysis results is very difficult, because many other gene variants were also identified in individuals with either c.470T > C or c.1100delC variants and some of the variant carriers had not (yet) been diagnosed with BrCa.